Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pain in Neonates During Screening for Retinopathy of Prematurity Using Two Methods (RETCAM)

This study has been completed.
Sponsor:
Information provided by:
NHS Lothian
ClinicalTrials.gov Identifier:
NCT00895869
First received: May 7, 2009
Last updated: February 24, 2010
Last verified: February 2010
  Purpose
Retinopathy of prematurity screening is painful. Wide field digital retinal imaging (WFDRI) and binocular indirect ophthalmoscopy (BIO) are being used for screening examinations. The aim of Edinburgh, UK based study is to compare the pain experienced by infants using both examination techniques.

Condition
Retinopathy of Prematurity
Pain

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Pain in Neonates During Screening for Retinopathy of Prematurity Using Binocular Indirect Ophthalmoscopy and Wide-field Digital Retinal Imaging: a Randomized Comparison

Resource links provided by NLM:


Further study details as provided by NHS Lothian:

Enrollment: 76
Study Start Date: April 2004
Study Completion Date: February 2008
Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)
Detailed Description:
Infants undergoing routine eye screening at Edinburgh Royal Infirmary Neonatal Intensive Care Unit are to be recruited. Infants will be excluded if they require mechanical ventilation or analgesic medication or if they have moderate/severe neurological impairment. The first screening examination for each baby was included. Infants' eyes will be examined by both WFDRI and BIO with eyelid speculum by 2 experienced pediatric ophthalmologists in random order. Observations will be video-recorded during examinations to generate a pain score (premature infant pain profile) for both WFDRI and BIO. The pain scores, heart rates, oxygen saturations and time taken for WFDRI and BIO will be compared using paired t tests.
  Eligibility

Ages Eligible for Study:   up to 32 Weeks   (Child)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Premature infants
Criteria

Inclusion Criteria:

  • Infants born at less than 32 weeks gestation and/or birth weight of less than 1500g.

Exclusion Criteria:

  • Infants requiring mechanical ventilation
  • Infants requiring analgesic medication
  • Infants with moderate/sever neurological impairment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00895869

Locations
United Kingdom
NHS Lothian
Edinburgh, United Kingdom
Sponsors and Collaborators
NHS Lothian
Investigators
Study Chair: Dr B Fleck, MBChB FRCOpth BSc(Hons) MD NHS Lothian
Principal Investigator: Dr C Dhaliwal, BSc(Hons) MBChB MRCPCH NHS Lothian
  More Information

Responsible Party: Dr Tina Mclelland, R&D Governance Manager, NHS Lothian
ClinicalTrials.gov Identifier: NCT00895869     History of Changes
Other Study ID Numbers: BF01  JB001  RF001 
Study First Received: May 7, 2009
Last Updated: February 24, 2010
Health Authority: United Kingdom: National Health Service

Keywords provided by NHS Lothian:
Screening
Retinopathy
Prematurity
Pain

Additional relevant MeSH terms:
Retinal Diseases
Premature Birth
Retinopathy of Prematurity
Eye Diseases
Obstetric Labor, Premature
Obstetric Labor Complications
Pregnancy Complications
Infant, Premature, Diseases
Infant, Newborn, Diseases

ClinicalTrials.gov processed this record on September 27, 2016